Literature DB >> 20401169

Role of RNA-Binding Proteins in Colorectal Carcinogenesis.

Shrikant Anant1, Courtney W Houchen, Vaibhav Pawar, Satish Ramalingam.   

Abstract

RNA-binding proteins (RBPs) play key roles in the posttranscriptional regulation of gene expression. RBPs control various posttranscriptional events, including splicing, polyadenylation, mRNA stability, transport, and translation. It is becoming apparent that RBPs play a significant role in pathophysiologic conditions such as inflammation and cancer. More importantly, we and others have begun dissecting the role of mRNA stability and translation in regulating gene expression, dysregulation of which has serious consequences for the fate of the cell. In this article, we discuss this emerging area of posttranscriptional gene regulation and the role of RBPs in the aberrant expression of proteins in tumorigenesis.

Entities:  

Year:  2010        PMID: 20401169      PMCID: PMC2853959          DOI: 10.1007/s11888-010-0048-z

Source DB:  PubMed          Journal:  Curr Colorectal Cancer Rep        ISSN: 1556-3790


  46 in total

Review 1.  HuR and mRNA stability.

Authors:  C M Brennan; J A Steitz
Journal:  Cell Mol Life Sci       Date:  2001-02       Impact factor: 9.261

Review 2.  The cdc25 M-phase inducer: an unconventional protein phosphatase.

Authors:  J B Millar; P Russell
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

Review 3.  EJCs at the heart of translational control.

Authors:  Hervé Le Hir; Bertrand Séraphin
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

4.  Developmentally-regulated expression of mNapor encoding an apoptosis-induced ELAV-type RNA binding protein.

Authors:  D K Choi; T Ito; F Tsukahara; M Hirai; Y Sakaki
Journal:  Gene       Date:  1999-09-03       Impact factor: 3.688

5.  Role of the RNA-binding protein HuR in colon carcinogenesis.

Authors:  Isabel López de Silanes; Jinshui Fan; Xiaoling Yang; Alan B Zonderman; Olga Potapova; Ellen S Pizer; Myriam Gorospe
Journal:  Oncogene       Date:  2003-10-16       Impact factor: 9.867

6.  Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo.

Authors:  Sripathi M Sureban; Randal May; Robert J George; Brian K Dieckgraefe; Howard L McLeod; Satish Ramalingam; Kumar S Bishnupuri; Gopalan Natarajan; Shrikant Anant; Courtney W Houchen
Journal:  Gastroenterology       Date:  2008-03-04       Impact factor: 22.682

7.  Translation initiation from the ribosomal A site or the P site, dependent on the conformation of RNA pseudoknot I in dicistrovirus RNAs.

Authors:  Nobuhiko Kamoshita; Akio Nomoto; Uttam L RajBhandary
Journal:  Mol Cell       Date:  2009-07-31       Impact factor: 17.970

8.  The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.

Authors:  Lisa E Young; Sandhya Sanduja; Kristi Bemis-Standoli; Edsel A Pena; Robert L Price; Dan A Dixon
Journal:  Gastroenterology       Date:  2009-01-15       Impact factor: 22.682

9.  Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.

Authors:  Jodi M Saunus; Juliet D French; Stacey L Edwards; Dianne J Beveridge; Esme C Hatchell; Sarah A Wagner; Sandra R Stein; Andrew Davidson; Kaylene J Simpson; Glenn D Francis; Peter J Leedman; Melissa A Brown
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

10.  CUGBP2 downregulation by prostaglandin E2 protects colon cancer cells from radiation-induced mitotic catastrophe.

Authors:  Gopalan Natarajan; Satish Ramalingam; Ilangovan Ramachandran; Randal May; Lurdes Queimado; Courtney W Houchen; Shrikant Anant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-03-06       Impact factor: 4.052

View more
  7 in total

1.  The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.

Authors:  Lisa E Young; Ashleigh E Moore; Lena Sokol; Nicole Meisner-Kober; Dan A Dixon
Journal:  Mol Cancer Res       Date:  2011-11-02       Impact factor: 5.852

Review 2.  MicroRNA and AU-rich element regulation of prostaglandin synthesis.

Authors:  Ashleigh E Moore; Lisa E Young; Dan A Dixon
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

3.  Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer.

Authors:  Satish Ramalingam; Prabhu Ramamoorthy; Dharmalingam Subramaniam; Shrikant Anant
Journal:  Immunogastroenterology       Date:  2012

Review 4.  Mechanistic aspects of COX-2 expression in colorectal neoplasia.

Authors:  Dan A Dixon; Fernando F Blanco; Annalisa Bruno; Paola Patrignani
Journal:  Recent Results Cancer Res       Date:  2013

5.  Zinc at cytotoxic concentrations affects posttranscriptional events of gene expression in cancer cells.

Authors:  Jie Zheng; Xiao-Xi Zhang; Haijun Yu; Jori E Taggart; Wei-Qun Ding
Journal:  Cell Physiol Biochem       Date:  2012-03-01

6.  The RNA-binding protein ESRP1 promotes human colorectal cancer progression.

Authors:  Sharmila Fagoonee; Gabriele Picco; Francesca Orso; Arrigo Arrigoni; Dario L Longo; Marco Forni; Irene Scarfò; Adele Cassenti; Roberto Piva; Paola Cassoni; Lorenzo Silengo; Emanuela Tolosano; Silvio Aime; Daniela Taverna; Pier Paolo Pandolfi; Mara Brancaccio; Enzo Medico; Fiorella Altruda
Journal:  Oncotarget       Date:  2017-02-07

Review 7.  Potential targets for colorectal cancer prevention.

Authors:  Sally Temraz; Deborah Mukherji; Ali Shamseddine
Journal:  Int J Mol Sci       Date:  2013-08-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.